These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7063798)

  • 1. [Muscular toxicity due to fenofibrate. Apropos of a case].
    Giraud P; Cassou M; Paul R; Guidet M
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):162. PubMed ID: 7063798
    [No Abstract]   [Full Text] [Related]  

  • 2. Fenofibrate-induced myopathy.
    Ghosh B; Sengupta S; Bhattacharjee B; Majumder A; Sarkar SB
    Neurol India; 2004 Jun; 52(2):268-9. PubMed ID: 15269493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myopathy caused by a combination rosuvastatin and fenofibrate.
    Dedhia V; Munsi SC
    J Assoc Physicians India; 2007 Feb; 55():152-3. PubMed ID: 17571748
    [No Abstract]   [Full Text] [Related]  

  • 4. [Morphometric study of hepatic peroxisomes in hyperlipoproteinemic patients treated with fenofibrate].
    Gariot P; Pointel JP; Barrat E; Drouin P; Debry G
    Biomed Pharmacother; 1984; 38(2):101-6. PubMed ID: 6743770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypothyroidism and muscular toxicity from fenofibrate, report of a case revealed by polymyositis].
    Cherif O; Karma F; Ben Amor G; Kochbati S; Ben Amor B; Rokbani L
    Tunis Med; 1997 Feb; 75(2):87-91. PubMed ID: 9506029
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)].
    Fromantin M; Gautier D; Quatre JM; Bon R
    Therapie; 1981; 36(4):473-6. PubMed ID: 7292431
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fenofibrate: animal toxicology in relation to side-effects in man (author's transl)].
    Blane GF; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3737-46. PubMed ID: 7208340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare side-effects of fenofibrate.
    Rabasa-Lhoret R; Rasamisoa M; Avignon A; Monnier L
    Diabetes Metab; 2001 Feb; 27(1):66-8. PubMed ID: 11240449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fenofibrate-induced photosensitivity.
    Leenutaphong V; Manuskiatti W
    J Am Acad Dermatol; 1996 Nov; 35(5 Pt 1):775-7. PubMed ID: 8912578
    [No Abstract]   [Full Text] [Related]  

  • 10. [Myopathy caused by fenofibrate].
    Solsona L; Coll J; Ariza A; Olivé A
    Med Clin (Barc); 1991 Nov; 97(17):677. PubMed ID: 1762464
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced high-density lipoprotein cholesterol in patients receiving rosiglitazone and fenofibrate.
    Venero CV; Thompson PD; Fernandez AB
    Am J Med; 2008 Oct; 121(10):e3-4. PubMed ID: 18823843
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Muscular toxicity caused by fenofibrate].
    Muller JP; Mazingue A; Cotes F; Destée A; Warot P
    Presse Med; 1989 May; 18(20):1033. PubMed ID: 2524802
    [No Abstract]   [Full Text] [Related]  

  • 14. [Septic-toxic shock due to rhabdomyolysis in a patient treated with fenofibrate].
    Duda-Król W; Jórasz I; Dabrowska M; Polubiec A; Kusz-Rynkun A
    Wiad Lek; 2000; 53(7-8):454-7. PubMed ID: 11070769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenofibrate can increase serum creatinine levels in renal insufficiency.
    Paul S; Mohan V
    J Assoc Physicians India; 2006 Apr; 54():337. PubMed ID: 16944623
    [No Abstract]   [Full Text] [Related]  

  • 16. Gynecomastia associated with fenofibrate.
    Gardette V; Vezzosi D; Maiza JC; Montastruc JL; Olivier P
    Ann Pharmacother; 2007 Mar; 41(3):508-10. PubMed ID: 17341535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate-associated reversible acute allograft dysfunction in 3 renal transplant recipients: biopsy evidence of tubular toxicity.
    Angeles C; Lane BP; Miller F; Nord EP
    Am J Kidney Dis; 2004 Sep; 44(3):543-50. PubMed ID: 15332227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure secondary to fenofibrate monotherapy-induced rhabdomyolysis.
    Tahmaz M; Kumbasar B; Ergen K; Ure U; Karatemiz G; Kazancioglu R
    Ren Fail; 2007; 29(7):927-30. PubMed ID: 17994463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
    Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.